Covid-19 breath test could give you results in 60 seconds
Finding a powerful drug and an efficient method to deliver it, has been the biggest challenge in the development of a faultless therapeutic strategy to combat COVID-19. Providing a potential treatment option, a new study has shown that inhalable nanobodies that target the SARS-CoV-2 coronavirus spike protein can help prevent and treat severe cases of the disease.
Scientists from the University of Pittsburgh, using a hamster model, demonstrated that low doses of an inhalable (or aerosolized) nanobody called Pittsburgh inhalable Nanobody-21 (PiN-21) can prevent and treat acute COVID-19. This is the first time that the nanobodies which are similar to monoclonal antibodies (only smaller in size and more stable) have been tested for treatment via inhalation against coronavirus infections in a pre-clinical model.
Scientists from the University of Pittsburgh School of Medicine have demonstrated that inhalable nanobodies can prevent and cure severe COVID-19 in hamsters by targeting the spike protein of the SARS-CoV-2 coronavirus.
People Are Reporting Unexpected Side Effects After COVID-19 Vaccination—But That's Actually Normal yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.